(S)-1-(5-chloro-2-((3,5-difluorophenyl)amino)pyrimidin-4-yl)-N-(3-(4-methylpiperazine-1-carbonyl)-4-(piperidin-1-yl)phenyl)pyrrolidine-2-carboxamide

ID: ALA4854719

PubChem CID: 164612348

Max Phase: Preclinical

Molecular Formula: C32H37ClF2N8O2

Molecular Weight: 639.15

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(C(=O)c2cc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)ccc2N2CCCCC2)CC1

Standard InChI:  InChI=1S/C32H37ClF2N8O2/c1-40-12-14-42(15-13-40)31(45)25-19-23(7-8-27(25)41-9-3-2-4-10-41)37-30(44)28-6-5-11-43(28)29-26(33)20-36-32(39-29)38-24-17-21(34)16-22(35)18-24/h7-8,16-20,28H,2-6,9-15H2,1H3,(H,37,44)(H,36,38,39)/t28-/m0/s1

Standard InChI Key:  FSQVEFNHIKVKSB-NDEPHWFRSA-N

Molfile:  

 
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
   33.8318   -6.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6348   -6.6975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4938   -5.3784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8301   -5.4447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.3853   -4.0923    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.1878   -4.4824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7429   -5.7128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.0571   -5.7169    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.6049   -4.4877    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2181   -4.8960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6113   -5.3064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4328   -3.7693    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   30.1906   -5.3086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8807   -5.6687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0537   -4.8656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4900   -6.2193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0424   -5.9867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4438   -4.3189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0496   -4.0246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4766   -4.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0322   -5.3052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7677   -5.3091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4742   -3.2524    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.9017   -5.7158    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.3189   -5.7140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0313   -4.4836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8287   -4.6123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4784   -5.7179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4391   -5.1551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2709   -5.9631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6638   -4.5753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7689   -4.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3112   -4.0724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8804   -6.5042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.7112   -7.3046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3164   -7.8484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0944   -7.5970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2636   -6.7966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6549   -6.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1693   -3.8383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3377   -3.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7277   -2.4883    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9465   -2.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7752   -3.5494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8972   -1.6889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 24 11  1  0
 22 28  1  0
 16 30  2  0
 14 16  1  0
 29 27  2  0
 26 12  1  0
 27 15  1  0
 13 24  1  0
 30 29  1  0
 10  4  2  0
 20 32  1  0
 20 23  1  0
 25 21  1  0
 22  8  1  0
 28 13  2  0
 10  5  1  0
 31 18  1  0
 26 33  1  0
 21 26  2  0
  3 31  1  6
  3  7  1  0
 11 25  2  0
 31 19  2  0
  6 20  2  0
 32 22  2  0
 17  3  1  0
  1  2  1  0
 21  7  1  0
 13  6  1  0
  7  1  1  0
  2 17  1  0
 18 15  1  0
  9 11  1  0
 29 10  1  0
 15 14  2  0
 33  9  2  0
 34 35  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 30 34  1  0
  5 40  1  0
  5 44  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 42 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4854719

    ---

Associated Targets(Human)

KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 639.15Molecular Weight (Monoisotopic): 638.2696AlogP: 5.14#Rotatable Bonds: 7
Polar Surface Area: 96.94Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.06CX Basic pKa: 6.82CX LogP: 5.39CX LogD: 5.29
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.37Np Likeness Score: -1.74

References

1. Li T, Li C, Yang J, Guo M, Cao Z, Wang X, Jiang N, Zhai X..  (2021)  Discovery of novel 2-phenylamino-4-prolylpyrimidine derivatives as TRK/ALK dual inhibitors with promising antitumor effects.,  47  [PMID:34534734] [10.1016/j.bmc.2021.116396]

Source